Methotrexate Injection — FDA Drug Shortage

No longer listed by FDA — Assertio Specialty Pharmaceuticals, LLC

The FDA lists a drug shortage record for Methotrexate Injection (injection) from Assertio Specialty Pharmaceuticals, LLC with status No longer listed by FDA. The shortage was first posted on Aug 29, 2025.

Shortage details

Status
No longer listed by FDA
Company
Assertio Specialty Pharmaceuticals, LLC
Package NDC
82497-022-04
Dosage Form
Injection
Presentation
Otrexup, Injection, 22.5 mg/.4 mL (NDC 82497-022-04)
Initial Posting
Aug 29, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.